PremiumCompany Announcements3SBio Partners with Pfizer for Global Licensing of Oncology Antibody 3SBio’s 707 Injection Receives Breakthrough Therapy Designation in China 3SBio (TRSBF) Announces Q3 Dividend: Read On for Important Dates PremiumCompany Announcements3SBio Partners with Duality Biologics for HER2 ADC Drug Commercialization 3SBio Cancels Treasury Shares and Relocates Office 3SBio Partners with Sunshine Lake Pharma for Drug Rights PremiumCompany Announcements3SBio Awards Shares to Top Performers 3SBio Reports Strong Growth in H1 2024 3SBio Inc. to Review H1 2024 Financials and Dividend